Balversa 4 MG tablet 56S
Ended Awarded
- Contract number
- SPE2DB25FP85E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,246
Award facts
- Contract value 100% obligated
- $51,246.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $51,246.46 on September 26, 2025, for the supply of Balversa 4 mg tablets (56-count units). This non-competitive delivery order, with firm fixed pricing, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 20, 2025. Balversa (erdafitinib) is a targeted cancer therapy used in the treatment of certain urothelial carcinomas, representing a specialized pharmaceutical product within the broader federal medical supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems through this comprehensive contract vehicle, which authorizes the supply of specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains to support military healthcare programs worldwide. The company's consistent receipt of competitive awards demonstrates its established capability to meet federal procurement requirements for complex pharmaceutical products and medical supplies.
Quick answers
Who was awarded contract SPE2DB25FP85E?
SPE2DB25FP85E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FP85E worth?
The government has obligated $51,246 on SPE2DB25FP85E.
Is contract SPE2DB25FP85E an order under another contract?
Yes. SPE2DB25FP85E is a delivery order under SPE2DB20D1109, an indefinite delivery contract.
Was contract SPE2DB25FP85E competed?
The extent of competition for SPE2DB25FP85E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award